Preclinical Developments of a Novel Therapeutic to Rejuvenate Aging Muscle Stem Cells and Enhance Muscle Strength and Function Post Hip Fracture

Grants and Contracts Details

StatusFinished
Effective start/end date9/30/218/31/23

Funding

  • Ridgeline Therapeutics: $353,863.00